Neurosurgery by Enam, S. Ather
Pakistan Journal of
Neurological Sciences (PJNS)





Follow this and additional works at: https://ecommons.aku.edu/pjns
Part of the Neurology Commons
Recommended Citation
Enam, S. Ather (2006) "Neurosurgery," Pakistan Journal of Neurological Sciences (PJNS): Vol. 1 : Iss. 2 , Article 8.
Available at: https://ecommons.aku.edu/pjns/vol1/iss2/8
V O L .  1 ( 2 )   J U L - S E P  2 0 0 6P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S  113
L I T E R A T U R E  H I G H L I G H T S
NEUROSURGERY
Gupta SK, Mohindra S, Sharma BS, Gupta R, Chhabra R, Mukherjee KK, Tewari MK, Pathak A, Khandelwal N,
Suresh NM, Khosla VK. 
Department of Neurosurgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India. drgupta_sk@yahoo.co.in
Selected abstracts and commentary
Neurosurgery. 2006 Jun;58(6):1144-50; discussion 1144-50.
OBJECTIVE: Tuberculosis of the craniovertebral junction is an
uncommon entity and its optimal management remains
controversial. In this study, we present the evolution of
management protocol of this disease in our institute in the
past 3 decades. M E T H O D S : A total of 51 patients with
craniovertebral junct ion tuberculos is  presenting as
TUBERCULOSIS OF THE CRANIOVERTEBRAL JUNCTION:
IS SURGERY NECESSARY?  
COMMENTARY
Neurosurgery is still one of the fastest evolving areas of medicine.  A little more than half a century ago, through the careful
observations, shrewd judgment, and meticulous technique of pioneers such as Harvey Cushing and Walter Dandy (to name
just a couple), this field gained acceptance.  In the 1970s use of the operating microscope and popularization of
microsurgical techniques by Gazi Yasargil and others produced excellent results and elevated neurosurgery to a higher level
of performance and capability. In the 1980s and 1990s, the introduction of minimally invasive techniques and radiosurgery
brought neurosurgery into a new era yet. The field continues to evolve and now with the concept of nano-neurosurgery on
the horizon we are contemplating a quantum leap in this specialty.
Reviewing the literature of the last three months one gets a very clear impression of the ever-evolving nature of
neurosurgery. Of the abstracts reproduced here, the first one by Gupta et al provides valuable data on the treatment
strategy of craniovertebral tuberculosis which has been a surgical problem by common opinion. Although their sample size
is modest, they show that rigid external fixation may suffice as an effective treatment and obviate the need of surgery. The
next abstract on the other hand confirms the observation developed over the last two decades that a disease that was
largely medical may have better results with surgical management and may be more feasible: Cohen-Gadol et al from Mayo
clinic report the long-term outcome of patients with epilepsy surgery on temporal lobes in cases where seizures were not
due to any lesions.  In 81% the outcome was excellent - they were either seizure-free or had aura or seizures only
transiently on drug withdrawal. About three quarters of these patients were able to maintain excellent status in a 10-year
follow-up. 
The next three abstracts (Regis et al, Mingione et al, and Soderman et al) point out the feasibility of radiosurgery in
neurosurgical problems. These include a randomized controlled trial on the safety and efficacy of radiosurgery for trigeminal
neuralgia, observations on the efficacy of gamma knife on the recurrent or residual pituitary macroadenoma, and use of
radiosurgery in dural arterio-venous fistulas. Traditionally, all three problems have been surgical but now radiosurgery is
emerging as a distinctly feasible alternative. The last three abstracts by Leary et al (Michael Apuzzo, editor of Neurosurgery,
is a co-author) point out the future direction in which the field of neurosurgery may show tremendous growth.
Nanotechnology may ultimately change this specialty more than any other advances have done so far.
S. Ather Enam
Associate Professor of Neurosurgery
Aga Khan University Medical College
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Cohen-Gadol AA, Wilhelmi BG, Collignon F, White JB, Britton JW, Cambier DM, Christianson TJ, Marsh WR,
Meyer FB, Cascino GD
Department of Neurologic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55902, USA. acohenmd@gmail.com
J Neurosurg. 2006 Apr;104(4):513-24
O B J E C T : The authors reviewed the long-term outcome of
focal resection in a large group of patients who had
intractable partial nonlesional epilepsy, including mesial
temporal lobe sclerosis (MTS), and who were treated
consecutively at a single institution. The goal of this study was
to evaluate the long-term efficacy of epilepsy surgery and the
preoperative factors associated with seizure outcome.
M E T H O D S : This retrospective analysis  inc luded 399
consecutive patients who underwent epilepsy surgery at Mayo
Clinic in Rochester, Minnesota, between 1988 and 1996.
The mean age of the patients at surgery was 32 +/- 12 years
(range 3-69 years), and the mean age at seizure onset was
12 +/- 11 years (range 0-55 years). There were 214 female
(54%) and 185 male (46%) patients. The mean duration of
epilepsy was 20 +/- 12 years (range 1-56 years). The
preceding values are given as the mean +/- standard
deviation. Of the 399 patients, 237 (59%) had a history of
complex partial seizures, 119 (30%) had generalized seizures,
26 (6%) had simple partial seizures, and 17 (4%) had
experienced a combination of these. Preoperative evaluation
included a routine and video-electroencephalography
recordings, magnetic resonance imaging of the head
according to the seizure protocol, neuropsychological testing,
and a sodium amobarbital study. Patients with an undefined
epileptogenic focus and discordant preoperative studies
underwent an intracranial study. The mean duration of follow
up was 6.2 +/- 4.5 years (range 0.6-15.7 years). Seizure
outcome was categorized based on the modified Engel
classification. Time-to-event analysis was performed using
Kaplan-Meier curves and Cox regression models to evaluate
the risk factors associated with outcomes. Among these
patients, 372 (93%) underwent temporal and 27 (7%) had
extratemporal resection of their epileptogenic focus.
Histopathological examination of the resected specimens
revealed MTS in 113 patients (28%), gliosis in 237 (59%),
and normal findings in 49 (12%). Based on the Kaplan-Meier
analysis, the probability of an Engel Class I outcome (seizure
free, auras, or seizures related only to medication withdrawal)
for the overall patient group was 81% (95% confidence
interval [CI] 77-85%) at 6 months, 78% (CI 74-82%) at 1
year, 76% (CI 72-80%) at 2 years, 74% (CI 69-78%) at 5
years, and 72% (CI 67-77%) at 10 years postoperatively. The
rate of Class I outcomes remained 72% for 73 patients with
more than 10 years of follow up. If a patient was in Class I at
1 year postoperatively, the probability of seizure remission at
10 years postoperatively was 92% (95% CI 89-96%); almost
all seizures occurred during the 1st year after surgery. Factors
predictive of poor outcome from surgery were normal
pathological findings in resected tissue (p = 0.038), male sex
(p = 0.035), previous surgery (p < 0.001), and an
ext ratemporal origin of se izures (p < 0.001).
CONCLUSIONS: The response to epilepsy surgery during the
1st follow-up year is a reliable indicator of the long-term Engel
Class I postoperative outcome. This finding may have
important implications for  patient counseling and
postoperative discontinuation of anticonvulsant medications.
LONG-TERM OUTCOME OF EPILEPSY SURGERY AMONG 399 PATIENTS WITH NONLESIONAL
SEIZURE FOCI INCLUDING MESIAL TEMPORAL LOBE SCLEROSIS
atlantoaxial dislocation from 1978 through 2004 were
reviewed. The disease was rated from Stage I to Stage III,
depending on the radiological findings. All patients received
antitubercular treatment for 18 months. In the initial period
of this study (1978-1986), all patients (n = 10) underwent
surgery, usually a posterior fusion. In the second period
(1987-1998), patients with less severe disease (Stages I
and II , n = 14) were managed with external r igid
immobilization, whereas patients with severe disease (Stage
III, n = 11) underwent either a transoral decompression with
or without posterior fusion or posterior fusion alone. More
recently (1999-2004), all patients (n = 16) in all stages
(Stages I-III) have been managed without surgery by a rigid
external immobilization. R E S U L T S : Except for two patients
who died (one because of miliary tuberculosis, the other
because of acute hydrocephalus), clinical recovery occurred
in all. Follow-up imaging demonstrated radiological healing
as well, with regrowth of the destroyed bone. CONCLUSION:
The mainstay of management of tuberculosis of  the
craniovertebral junction is prolonged antitubercular treatment
with a rigid external immobilization. Surgery is not necessary,
even in patients with advanced stages of disease. Complete
clinical and radiological healing occurs in all patients with
conservative treatment.
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Mingione V, Yen CP, Vance ML, Steiner M, Sheehan J, Laws ER, Steiner L
Department of Neurological Surgery, Lars Leksell Center for Gamma Surgery, University of Virginia Health System, Charlottesville, Virginia 22908, USA
J Neurosurg. 2006 Jun;104(6):913-24
O B J E C T : The authors report on a retrospective analysis of
the imaging and clinical outcomes following gamma surgery
in 100 patients with nonsecretory pituitary macroadenoma.
M E T H O D S : Between June 1989 and March 2004, 100
consecut ive patients wi th nonsecretory pi tuitary
macroadenoma were treated at the Lars Leksell Center for
Gamma Surgery, University of Virginia Health System
(Charlottesville, VA). Ninety-two patients had residual or
recurrent macroadenoma following one or more surgical
procedures. In eight patients, gamma surgery was the
primary treatment. Ten patients received conventional
fractionated radiotherapy before the gamma surgery. Sixty-
nine patients required hormone replacement therapy for one
or more deficits before gamma knife treatment. Peripheral
doses between 5 and 25 Gy (mean 18.5 Gy) were
administered. Imaging and endocrinological follow-up
evaluations were performed in 90 patients; these studies
ranged from 6 to 142 months (mean 44.9 months) and 6 to
127 months (mean 47.9 months), respectively. Tumor
volume decreased in 59 patients (65.6%), remained
unchanged in 24 (26.7%), and increased in seven (7.8%).
The minimal effective peripheral dose was 12 Gy; peripheral
doses greater than 20 Gy did not seem to provide additional
benefit. Of 61 patients with a partially or fully functioning
pituitary gland and follow-up data, 12 (19.7%) suffered new
hormone deficits following gamma surgery. In patients with
endocrinological follow-up data that had been collected over
more than 2 years, the rate of new deficits was 25%. No
neurological morbidity or death was related to treatment.
CONCLUSIONS: Current experience suggests that gamma
surgery is an appropriate means of managing recurrent or
residual nonsecretory pituitary macroadenoma following
microsurgery and a primary treatment in selected patients.
To evaluate definite rates of recurrence and new endocrine
deficiencies, long-term follow-up studies are needed.
GAMMA SURGERY IN THE TREATMENT OF NONSECRETORY PITUITARY MACROADENOMA
Regis J, Metellus P, Hayashi M, Roussel P, Donnet A, Bille-Turc F
Departments of Functional Neurosurgery and Neurology, Timone University Hospital, Marseille, France. jregis@ap-hm.fr
J Neurosurg. 2006 Jun;104(6):913-24
O B J E C T : Stereotactic radiosurgery is an alternative to
conventional surgery for  the treatment of trigeminal
neuralgia. The authors conducted a prospective evaluation of
the safety and efficacy of this method in a large series of
patients. METHODS: A total of 100 patients presenting with
trigeminal neuralgia were treated and followed up for a
minimum of 12 months. The mean age was 68.2 years; 54
patients were male, and 46 were female. Seven had a
history of multiple sclerosis, and 42 had already received
conventional surgical treatment for trigeminal neuralgia. The
intervention consisted of gamma knife surgery to the
retrogasserian cisternal portion of the fifth cranial nerve. The
median dose used at the maximum was 85 Gy (range 70-90
Gy). The number and intensity of pain attacks were recorded
by the patient from 3 months before radiosurgery to a
minimum of 12 months after treatment. Before and a
minimum of 12 months after treatment, the patient
completed a quality-of-life questionnaire. Neurological
examination and quantitative sensory testing to evaluate
sensory perception were performed by an independent
neurologist over this same time period. At the last visit 83 of
100 patients were reported to be pain free. Fifty-eight of
these 83 patients had stopped taking medication during the
study. All quality-of-life parameters were improved (p <
0.001). Six patients reported facial paresthesia, and four
patients reported hypesthesia. These symptoms were
classified as mild. None of the complications reported for
other  techniques were observed. C O N C L U S I O N S :
Radiosurgery is a safe and effective alternative treatment for
trigeminal neuralgia and is associated with a particularly low
rate of hypesthesia.
PROSPECTIVE CONTROLLED TRIAL OF GAMMA KNIFE SURGERY FOR ESSENTIAL
TRIGEMINAL NEURALGIA
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Soderman M, Edner G, Ericson K, Karlsson B, Rahn T, Ulfarsson E, Andersson T
Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden. michael.soderman@karolinska.se
J Neurosurg. 2006 Jun;104(6):867-75
O B J E C T : The aim of this study was to assess the clinical
efficacy of gamma knife surgery (GKS) in the treatment of
dural arteriovenous shunts (DAVSs). M E T H O D S : From a
database of more than 1600 patients with intracranial
arteriovenous shunts that had been treated with GKS, the
authors retrospectively and prospectively identified 53
patients with 58 DAVSs from the period between 1978 and
2003. Four patients were lost to follow-up evaluation and
were excluded from the series. Thus, this study is based on
the remaining 49 patients with 52 DAVSs. Thirty-six of the
shunts drained into the cortical venous system, either
directly or indirectly, and 22 of these were associated with
intracranial hemorrhage on patient presentation. The mean
prescription radiation dose was 22 Gy (range 10-28 Gy). All
patients underwent a clinical follow-up examination. In 41
cases of DAVS a follow-up angiography study was performed.
At the 2-year follow-up visi t,  28 cases (68%) had
angiographically proven obliteration of the shunt and in
another 10 cases (24%) there was sign if icant  f low
regression. Three shunts remained unchanged. There was
one immediate minor complicat ion related to the
administration of radiation. Furthermore, one patient had a
radiation-induced complication 10 years after treatment,
although she recovered completely. There was one posterior
fossa bleed 2 months after radiosurgery; a hematoma, as
well as a lesion, was evacuated, and the patient recovered
uneventfully. A second patient had an asymptomatic occipital
hemorrhage approximately 6 months postradiosurgery. The
clinical outcome after GKS was significantly better than that
in patients with naturally progressing shunts (p < 0.01, chi-
square test); figures on the latter have been reported
previously. C O N C L U S I O N S : Gamma knife surgery is an
effect ive treatment for  DAVSs, wi th a low risk of
complications. Major disadvantages of this therapy include
the time elapsed before obliteration and the possibility that
not all shunts will be obliterated. Cortical venous drainage
from a DAVS, a risk factor for intracranial hemorrhage, is
therefore a relative contraindication. Consequently, GKS can
be used in the treatment of both benign DAVSs with
subjectively intolerable bruit and aggressive DAVSs not
responsive to endovascular treatment or surgery.
GAMMA KNIFE SURGERY FOR DURAL ARTERIOVENOUS SHUNTS: 25 YEARS OF
EXPERIENCE
Regis J, Metellus P, Hayashi M, Roussel P, Donnet A, Bille-Turc F
Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
Neurosurgery. 2005 Oct;57(4):606-34; discussion 606-34
Since its  or iginal conception in 1959, the notion of
nanotechnology and its potential ramifications have not only
created fascination, but also intense scientific effort and
scrutiny. Currently, research activities are being principally
conducted in mesoscale, the realm between nanoscale and
macroscale, with the rudiments of nanoscience being
defined in realities and principles that will determine
activities and discoveries in the future. This paper reviews
and discusses the evo lution of  nanoscience, its
contemporary status, and the discoveries that currently
constitute the main components of the body of knowledge
from a neurosurgical perspective. Specific attention is given
to the developments in imaging, fabrication, nanostructures,
nanoelectromechanical systems, molecular manufacturing,
nanocomputation, and emerging physical and chemical
concepts in mesoscale, as they will establish foundations for
the realization of nanomedicine and nanoneurosurgery.
TOWARD THE EMERGENCE OF NANONEUROSURGERY: PART I--PROGRESS IN
NANOSCIENCE, NANOTECHNOLOGY, AND THE COMPREHENSION OF EVENTS IN THE
MESOSCALE REALM
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Leary SP, Liu CY, Apuzzo ML
Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
Neurosurgery. 2006 May;58(5):805-23; discussion 805-23
The notion of nanotechnology has evolved since its inception
as a fantastic conceptual idea to its current position as a
mainstream research initiative with broad applications
among all divisions of science. In the first part of this series,
we reviewed the structures and principles that comprise the
main body of knowledge of nanoscience and
nanotechnology.  In  the second part , we d iscussed
applications of nanotechnology to the emerging field of
nanomedicine, with specific attention on medical diagnostics
and imaging. This article further explores the applications of
nanotechnology to nanomedicine. Specific attention is given
to developments in therapeutic modalit ies, including
advanced drug delivery systems and targeted nanotherapy,
which will form the basis for the treatment arm of mature
nanomedicine. A variety of modalities are discussed,
including polymeric nanoparticles, micelles, liposomes,
dendrimers, fullerenes, hydrogels, nanoshells, and smart
surfaces. Applications of nanotechnology to nanosurgery and
nanoneurosurgery are presented. Femtosecond laser
systems, nanoneedles, and nanotweezers are presented as
technologies that are operational at the nanoscale level and
have the potent ia l to  revolut ionize the practice of
neurosurgery in a profound and momentous way.
TOWARD THE EMERGENCE OF NANONEUROSURGERY: PART III--NANOMEDICINE:
TARGETED NANOTHERAPY, NANOSURGERY, AND PROGRESS TOWARD THE REALIZATION OF
NANONEUROSURGERY
